These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 38369032)
1. Neurosteroids: A potential target for neuropsychiatric disorders. Wang M; Hu S; Fu X; Zhou H; Yang S; Yang C J Steroid Biochem Mol Biol; 2024 May; 239():106485. PubMed ID: 38369032 [TBL] [Abstract][Full Text] [Related]
2. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy. Żulińska S; Strosznajder AK; Strosznajder JB Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000217 [TBL] [Abstract][Full Text] [Related]
3. Developmental and adult stress: effects of steroids and neurosteroids. Gore IR; Gould E Stress; 2024 Jan; 27(1):2317856. PubMed ID: 38563163 [TBL] [Abstract][Full Text] [Related]
4. Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications. Cai H; Cao T; Zhou X; Yao JK Front Psychiatry; 2018; 9():73. PubMed ID: 29568275 [TBL] [Abstract][Full Text] [Related]
5. Neurosteroid replacement therapy for catamenial epilepsy, postpartum depression and neuroendocrine disorders in women. Reddy DS J Neuroendocrinol; 2022 Feb; 34(2):e13028. PubMed ID: 34506047 [TBL] [Abstract][Full Text] [Related]
6. The relevance of neurosteroids to clinical psychiatry: from the laboratory to the bedside. Strous RD; Maayan R; Weizman A Eur Neuropsychopharmacol; 2006 Apr; 16(3):155-69. PubMed ID: 16257183 [TBL] [Abstract][Full Text] [Related]
7. Steroid hormones and neurosteroids in normal and pathological aging of the nervous system. Schumacher M; Weill-Engerer S; Liere P; Robert F; Franklin RJ; Garcia-Segura LM; Lambert JJ; Mayo W; Melcangi RC; Parducz A; Suter U; Carelli C; Baulieu EE; Akwa Y Prog Neurobiol; 2003 Sep; 71(1):3-29. PubMed ID: 14611864 [TBL] [Abstract][Full Text] [Related]
9. Editorial: Steroids and the Brain. Ubuka T; Trudeau VL; Parhar I Front Endocrinol (Lausanne); 2020; 11():366. PubMed ID: 32582033 [No Abstract] [Full Text] [Related]
10. Dynamic Adaptation in Neurosteroid Networks in Response to Alcohol. Finn DA; Jimenez VA Handb Exp Pharmacol; 2018; 248():55-78. PubMed ID: 29242992 [TBL] [Abstract][Full Text] [Related]
11. Neurosteroid modulation of GABAA receptors: molecular determinants and significance in health and disease. Mitchell EA; Herd MB; Gunn BG; Lambert JJ; Belelli D Neurochem Int; 2008; 52(4-5):588-95. PubMed ID: 18055067 [TBL] [Abstract][Full Text] [Related]
12. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions. Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496 [TBL] [Abstract][Full Text] [Related]
13. Neurosteroids and sporadic Alzheimer's diseas. Barry G; Ross IL Curr Alzheimer Res; 2008 Aug; 5(4):367-374. PubMed ID: 18690831 [TBL] [Abstract][Full Text] [Related]
14. Neurosteroids as regulators of neuroinflammation. Yilmaz C; Karali K; Fodelianaki G; Gravanis A; Chavakis T; Charalampopoulos I; Alexaki VI Front Neuroendocrinol; 2019 Oct; 55():100788. PubMed ID: 31513776 [TBL] [Abstract][Full Text] [Related]
15. Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review. Marecki R; Kałuska J; Kolanek A; Hakało D; Waszkiewicz N Front Psychiatry; 2023; 14():1298359. PubMed ID: 38116383 [TBL] [Abstract][Full Text] [Related]
16. Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy. Gatta E; Camussi D; Auta J; Guidotti A; Pandey SC Pharmacol Ther; 2022 Dec; 240():108299. PubMed ID: 36323379 [TBL] [Abstract][Full Text] [Related]
17. Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Carver CM; Reddy DS Psychopharmacology (Berl); 2013 Nov; 230(2):151-88. PubMed ID: 24071826 [TBL] [Abstract][Full Text] [Related]
18. [New therapeutic avenues for neurosteroids in psychiatric diseases]. Froger N Biol Aujourdhui; 2019; 213(3-4):131-140. PubMed ID: 31829933 [TBL] [Abstract][Full Text] [Related]
19. Neurosteroids in child and adolescent psychopathology. Golubchik P; Lewis M; Maayan R; Sever J; Strous R; Weizman A Eur Neuropsychopharmacol; 2007 Feb; 17(3):157-64. PubMed ID: 17079119 [TBL] [Abstract][Full Text] [Related]
20. Modulation of Muscarinic Signalling in the Central Nervous System by Steroid Hormones and Neurosteroids. Szczurowska E; Szánti-Pintér E; Chetverikov N; Randáková A; Kudová E; Jakubík J Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]